Register today to receive your daily dose of health news. Get the latest information delivered to your inbox with our free dailyRx Newsletter!
Connect with the dailyRx social media channels to receive the latest health news and information and to stay up to date on dailyRx promotions!
Stay up to date with the health news that matters most! Choose from a wide selection of dailyRx Headlines™ news feeds and receive the latest headlines directly on your website as soon as news is published.
Explore our wide selection of money-saving coupons for medications and other health-related products.
Save money on your Rx medications with our printable and online medication discount card.
Learn how to reduce your medication costs with discount programs and other valuable savings resources directly from pharmaceutical companies.
Vincasar PFS (generic: vincristine) has been use in combination with other medicines to treat the following cancers: non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, acute lymphoblastic leukemia (ALL), Wilms’ tumor (a form of pediatric kidney cancer), rhabdomyosarcoma, and neuroblastoma. It has also been used in the treatment of the following blood disorders: thrombotic thrombocytopenic purpura (TTP) and idiopathic thrombocytopenic purpura (ITP).
Vincasar PFS belongs to a group of drugs called vinca alkaloids. It works by preventing cancer cells from properly dividing.
This medication comes in an injectable form to be given directly into a vein (IV) by a healthcare provider. It is usually given once a week.
Common side effects of Vincasar PFS include hairloss, nausea, vomiting, and diarrhea.